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Cyclooxygenase (COX)-1 and -2 catalyze the key reac-
tion in prostaglandin biosynthesis. Whereas COX-1 is
found in most tissues, COX-2, with a few exceptions,
is not expressed in normal tissues but becomes transi-
ently induced in the course of in£ammatory reactions.
In many neoplastic epithelia, COX-2 is constitutively
overexpressed. Here we show that COX isozymes are
spatiotemporally expressed during morphogenesis of
dorsal skin epithelium of NMRI mice. COX-1 and
COX-2 mRNA and protein were detected in embryonic
and postnatal epidermal tissue by RT-PCR, northern
blot, and immunoblot analysis indicating that both iso-
forms may contribute to prostaglandin production.
Being barely detectable in interfollicular epidermis and
resting hair follicles of adult mice, COX-2 protein ap-
peared in embryonic skin ¢rst in epidermal precursor
cells and later on in the basal cells and the peridermal
layer of the strati¢ed epidermis. In the course of pelage
hair follicle morphogenesis, COX-2 remained expressed
in the basal interfollicular compartment and, in addi-
tion, became apparent in elongated hair germs and hair
pegs and later on in the outer root sheath cells of the
distal and proximal hair follicles as well as in basal
sebaceous gland cells. During the subsequent synchro-
nous phases of hair cycling, COX-2 expression declined
in catagen, was barely detectable in telogen, and was
reinduced in the basal outer root sheath and basal
sebaceous gland cells of anagen hair follicles. COX-1
immunosignals were detected predominantly in the in-
terfollicular spinous and granular layers of the develop-
ing, neonatal, and adult epidermis but not in follicular
epithelial cells of developing or cycling hair follicles.
Dendritic cells in the interfollicular epidermis and dis-
tal hair follicles were also COX-1-positive. Transgenic
overexpression of COX-2 under the control of a keratin
5 promoter in basal cells of the interfollicular and folli-
cular epidermis induced a precocious entry into the ¢rst
catagen stage of postnatal hair follicle cycling and a
subsequent disturbance of hair follicle phasing. Further-
more, transgenic mice developed an alopecia. Inhi-
bition of transgenic COX-2 activity by feeding the
speci¢c COX-2 inhibitor valdecoxib suppressed the
development of alopecia, indicating that COX-2-
mediated prostaglandin synthesis is involved in hair
follicle biology. Keywords: epidermis/transgenic/valdecoxib.
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air follicle morphogenesis is regulated by interac-
tions between epidermal keratinocytes committed
to hair-follicle-speci¢c di¡erentiation and a subset
of specialized ¢broblasts with follicle-inductive
properties and committed to form the dermal pa-
pilla of the developing hair follicle (Hardy, 1992). These epithe-
lial^mesenchymal interactions ¢nally culminate in the formation
of the hair shaft, which is surrounded by the multilayered inner
root sheath, the companion layer, and the outer root sheath
(ORS), the latter being the outermost concentric layer of epithe-
lial cells (Winter et al, 1998; Fuchs and Raghavan, 2002). Once
fully developed, hair follicles undergo repeated cycles of regres-
sion and involution (catagen), rest (telogen), and renewal (ana-
gen) during the whole life span (Hardy, 1992; Fuchs et al, 2001;
Stenn and Paus 2001).
Distinct signaling pathways, such as the wnt/b-catenin, sonic
hedgehog, bone morphogenic protein, and noggin signaling cas-
cades, control hair follicle morphogenesis, postnatal hair growth,
and cycling (Botchkarev et al, 1999, 2002; Fuchs et al, 2001; Huels-
ken et al, 2001; Fuchs and Raghavan 2002). In addition, distinct
growth factors (Stenn and Paus 2001) and prostaglandin (PG)
types (Johnstone and Albert, 2002) seem to regulate hair follicle
growth and cycling in humans. In fact, stimulation of PGE2
synthesis is thought to be at least partly involved in the
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minoxidil-e¡ected induction and prolongation of the anagen
phase of normal human hair growth (Michelet et al, 1997).
Furthermore, inhibitors of PG synthesis including certain non-
steroidal anti-in£ammatory drugs have been reported to induce
alopecia in humans (Tosti et al, 1994; Pillans andWood, 1995).
PG are mainly synthesized from arachidonic acid, which serves
as a major substrate for cyclooxygenases (COX). These enzymes
generate the PG endoperoxide PGH2, which is subsequently con-
verted by prostanoid synthases into the biologically active prosta-
noids such as the prostaglandins PGE2, PGF2a, PGD2, PGI2, and
thromboxane A2 in a cell-type-speci¢c manner (Smith et al,
2000). There are two COX isozymes, i.e., a constitutive COX-1
and an inducible COX-2. COX-2 expression is stimulated by a
wide variety of growth factors, cytokines, and hormones, parti-
cularly in the course of in£ammatory processes (Wang and
Smart, 1999; Smith et al, 2000). In adult skin of mice with resting
hair follicles, COX-1 was found to be the major isoform ex-
pressed in keratinocytes of the interfollicular epidermis (IFE)
and the upper part of the hair follicle, whereas COX-2 protein
was barely detectable (Scholz et al, 1995; Mˇller-Decker et al,
1998) like in other adult tissues under nonpathological conditions
(Sorli et al, 1998; O’Banion, 1999; Smith et al, 1999; Kirschenbaum
et al, 2000). In contrast, a transient induction of COX-2 protein,
but not of COX-1, in the basal cells of the IFE, the ORS, and the
sebaceous gland was observed upon treatment of adult mouse
skin with the tumor promoter 12-O-tetradecanoylphorbol-13-
acetate (Scholz et al, 1995; Mˇller-Decker et al, 1998). Moreover,
upon depilation of adult mouse skin a transient induction of
COX-2 mRNAwas found in ORS cells of regrowing hair folli-
cles (Torii et al, 2002). Upon super¢cial (Scholz et al, 1995) and
incisional (Mˇller-Decker et al, 2002a) skin wounding, COX-2
protein was found to be transiently upregulated in the epidermis
as well as in the ORS of anagen hair follicles growing out into
the healing wound. Furthermore, in heterozygous transgenic
mice, a constitutive overexpression of COX-2 driven by the ker-
atin 5 (K5) promoter in the basal cells of the IFE and the pilose-
baceous unit led to a delayed emergence of hair shafts and a
reduced hair follicle density, as well as to sebaceous gland hyper-
plasia with concomitant overproduction of sebum (Neufang et al,
2001). Alopecia was also described as the gross phenotype of ker-
atin 14 (K14) COX-2 transgenic mice, which was suppressed by
treatment with the COX-2-selective inhibitor celecoxib. Neither
hair follicle morphogenesis and cycling nor alopecia, however,
were histologically analyzed (Bol et al, 2002).
Here we describe experiments showing a distinct spatiotem-
poral epidermal expression pattern of the two COX isozymes
during epidermal morphogenesis and hair follicle cycling in the
dorsal skin of mice. Moreover, in homozygous transgenic mice,
COX-2 overexpression resulting in overshooting PG synthesis
severely impaired hair follicles and induced alopecia.
MATERIALS AND METHODS
Materials Goat polyclonal anti-COX-1 (SC-1754), anti-COX-2 (SC-1745),
rabbit polyclonal anti-EP2 receptor (SC-20675), goat polyclonal anti-EP3
receptor (SCV-16019), goat polyclonal anti-EP4 receptor (SC-16022), goat
polyclonal anti-b-actin antibodies (SC-1616), peroxidase-conjugated goat
anti-rabbit IgG, and donkey anti-goat IgG antibodies were purchased
from Santa Cruz (Heidelberg, Germany). ELISA BSA and goat serum
were purchased from Sigma (Deisenhofen, Germany); rabbit polyclonal
anti-EP1 receptor antibody and PGE2 and PGF2a enzyme immunoassays
were from Cayman (Ann Arbor, MI). Aprotinin, leupeptin, and a2-
macroglobulin were from Roche Applied Sciences (Mannheim, Germany).
Animals Experiments were performed with wild-type NMRI mice
(outbred strain from RCC, Fˇllinsdorf, Switzerland) and the homozygous
K5 COX-2 transgenic line 675þ/þ , generated as described previously
(Neufang et al, 2001). All mice were kept in the central animal unit of the
DKFZ (Heidelberg, Germany) under an arti¢cial day/night rhythm and
were fed altromin standard food pellets and water ad libitum if not stated
otherwise. For analysis of hair follicle morphogenesis, embryonic and
neonatal skin was collected at distinct time points of estimated gestational
age (i.e., embryonic days (E) E13, E15, and E18 with the morning on which
a vaginal plug was found set E0.5) or at di¡erent postnatal ages (postnatal
days (P) P1, P4, P8, P11, P12 (hair follicle morphogenesis), P17, P20
(catagen), P21 (telogen), P25, P28, and P29 (1, anagen). In 7-week-old
(P49) adult mice with telogen hair follicles in dorsal skin, anagen hair
follicles were induced by depilation of hair shafts. Skin was taken for
analysis of hair follicles 3^25 d after depilation. Skin biopsies were
immediately frozen in liquid nitrogen or embedded in Tissue Tek (Vogel,
Gieen, Germany) and processed for immunohistochemistry as described
(Mˇller-Decker et al, 1998). All animal experiments have been approved by
the Governmental Committee for Animal Experimentation (license 150/97
and 011/02) and by the ethics committee of the DKFZ. To study the e¡ect
of a COX-2-selective inhibitor on the transgene-induced phenotype,
rodent diet 5010 containing 500 ppm valdecoxib was fed to transgenic
mice starting on day 1 after birth for 3 mo by delivering the diet to
nursing mice for 4 weeks and later on as regular chow.
RT-PCR and northern blot analysis Total RNA was extracted from
pulverized frozen tissues by using RNA Clean (AGS, Heidelberg,
Germany), and RT-PCR was performed with the cDNA cycle kit
(Invitrogen) as described (Mˇller-Decker et al, 1999). The sense and
antisense primers for COX-1 mRNAwere 50 -TGCATGTGGCTGTGGA-
TGTCATCAA-30 and 50 -CACTAAGACAGACCCGTCATCTCCA-30,
respectively, giving rise to a 448-bp PCR product. The ampli¢cation
conditions for COX-1were 951C for 5 min for one cycle and 941C for 90
s, 631C for 90 s, and 721C for 150 s for 40 cycles followed by one cycle for
10 min at 721C. The primers for COX-2 mRNAwere sense 50 -ACTCAC-
TCAGTTTGTTGAGTCATTC-30 and antisense 50 -TTTGATTAGTACT-
GTAGGGTTAATG-30 (583 bp, 941C/541C/721C, 40 cycles), for EP1
receptor were sense 50 -TAGTGTGCAATACGCTCAGCG-30 and antisense
50 -GAGGTGACTGAAACCACTGTG-30 (553 bp, 951C/641C/721C, 40 cycles),
for EP2 receptor were sense 50 -GACTGCATACCTTCAGCTGTAC-30 and
antisense 50 -TATGGCAAAGACCCAAGGG-30 (369 bp, 941C/581C/721C,
40 cycles), for EP3 receptor were sense 50 -GGCACGTGGTGCTTCATC-
30 and antisense 50 -GGGATCCAAGATCTGGTTC-30 (416 bp, 941C/541C/
721C, 40 cycles), for EP4 receptor were sense 50 -CTGAACAGCCCGGTG-
ACCATTCC-30 and antisense 50 -GCCGGCCAGCCGCTTGTCCAC-30
(363 bp, 951C/631C/721C, 40 cycles), and for b-actin as an internal
control were sense 50 -AAACTGGAACGGTGAAGGC-30 and antisense
50 -GCTGCCTCAACACCTCAAC-30 (429 bp, 941C/541C/721C, 30 cycles).
Signals by potential genomic contamination were ruled out by selection of
intron-spanning primers. In addition, samples without cDNAwere used as
negative controls. PCR was performed at least two times with a single
cDNA sample. RT-PCR products were found on sequencing by the
ABI prism to be 495% homolog to published sequences. Steady-state
mRNA levels of COX-1 and COX-2 in skin were studied as described
previously using isozyme-speci¢c cDNA probes (Mˇller-Decker et al,
1995; Scholz et al, 1995).
Immunoblot analysis Immunoprecipitation of COX-2 and COX-1 as
well as immunoblot analysis from skin were carried out by using
isoenzyme-speci¢c antisera samples as described previously (Mˇller-
Decker et al, 1998). For immunoblot analysis of prostaglandin E receptors
(EP receptors), frozen skin powder was homogenized in a bu¡er consisting
of 50 mM Tris^HCl, pH 7.4, 1% Tween 20, 2 mM EDTA, 1 mM
phenylmethylsulfonyl £uoride, 10 mg/mL aprotinin, 10 mg/mL leupeptin,
and 2 mM a2-macroglobulin. Debris was removed by centrifugation in a
Beckman GPKR at 2200g for 20 min at 41C. A total of 120 mg of
precipitated and denatured protein was separated by 7.5% sodium dodecyl
sulfate^polyacrylamide gel electrophoresis and transferred electro-
phoretically to polyvinylidene £uoride membranes as described (Mˇller-
Decker et al, 1995). Primary antibodies to EP receptors were used at a ¢nal
dilution of 1:250. The secondary horseradish peroxidase-conjugated anti-
IgG antibodies were used at a dilution of 1:2000. Immunodetection was
carried out using enhanced chemiluminescence reagent according to the
manufacturer’s instructions (Amersham Pharmacia, Buckinghamshire,
UK). The speci¢city of the immunosignals was con¢rmed by complete
quenching of the immunosignal upon preadsorption of the antiserum
with a 500-fold molar excess of the respective peptide antigen from Santa
Cruz or Cayman.
Histochemistry and immunohistochemistry For hematoxylin/eosin
staining, skin was ¢xed in PBS-bu¡ered 4% paraformaldehyde for 16 h
before embedding into para⁄n. For immunohistochemical staining,
5-mm cryosections were used. COX isozymes were immunodetected as
described (Mˇller-Decker et al, 1998; Neufang et al, 2001). Primary
antibodies were diluted 1:100 (COX-1 and -2), and peroxidase-conjugated
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secondary antibodies 1:100 in blocking solution. Development with
diaminobenzidine was used for visualization. Sections were counter-
stained with hematoxylin (Merck, Darmstadt, Germany), dehydrated,
and mounted with Eukitt (O. Kindler, Freiburg, Germany). Omission of
the primary antibody, or preincubation of the COX-isozyme-selective
antibodies with the peptides (500-fold molar excess) used for generation
of the antisera did abolish the staining (data not shown). Specimens were
examined by an Axioskop 2 microscope connected to an Axiocam
camera using Axiovision software (release 2.05, Zeiss, Goettingen,
Germany).
Determination of PG concentrations Immediately after excision,
biopsies were frozen in liquid nitrogen. Processing of samples and
quantitation of PG levels by means of commercially available enzyme
immunoassays were carried out as described (Mˇller-Decker et al, 2002b).
Histomorphometry For hair cycle staging, skin cryosections of K5
COX-2/675þ/þ and of age-matched wild-type mice were stained with
hematoxylin/eosin. The percentage of hair follicles in telogen, anagen, and
catagen stages were assessed in longitudinally cut hair follicles according to
published criteria without considering substages (Mˇller-R˛ver et al, 2001)
on P11, P17, P20, P29, and P49 after birth. Approximately 900 follicles in
sections from three wild-type and transgenic mice each were counted by
two independent investigators (G.F., K.M.D.). All sections were analyzed
at a 100-fold magni¢cation. Statistical di¡erences were evaluated by
Student’s t test. Di¡erences were considered to be signi¢cant with p values
o0.05.
RESULTS
COX isozyme expression in embryonic and postnatal
epidermis and its pilosebaceous appendage Using northern
blot and semiquantitative RT-PCR analysis, COX-1 and COX-2
mRNA expression was detected in total mouse embryos at E13
and E15, in skin preparations at E18, and at P1 and P11/12, i.e.,
the period of hair follicle morphogenesis (Fig 1A,B). Thereafter,
mRNA expression of COX-2 declined in postnatal skin with
catagen (P17/20) and telogen hair follicles (P21), increased again
during the anagen stage (P28), and was barely detectable in adult
skin with telogen hair follicles (P49). In contrast, COX-1mRNA
expression was similar through P12 to P21 and slightly increased
during the anagen stage (P28) and remained present in adult skin
(Fig 1A,B). COX-2 protein was demonstrated in embryonic skin
by immunoblot analysis representatively shown for E17 (Fig 1C).
Its expression persisted through P8 to P20 but was undetectable
in adult skin with resting hair follicles (P49). COX-1 protein
expression did not show noticeable alterations during this time
period (Fig 1C).
A more detailed immunohistochemical analysis con¢rmed
COX-2 expression in epithelial precursor cells of embryonic
epidermis at E13, i.e., prior to the onset of epidermal
strati¢cation (Fig 2A). At E15, COX-2 protein was present
in the basal cells as well as in the outermost ectodermal peri-
derm layer of the strati¢ed embryonic epidermis, whereas
di¡erentiated layers in between were negative (Fig 2B). From
E15 to E18, i.e., the time period of maximal induction of pelage
hair follicles (Hardy, 1992), COX-2 expression became apparent
in elongated hair germs and hair pegs of stages 2 and 3 (Paus et
al, 1999), whereas dermal papilla cells were negative (Fig 2C,C
inset). Upon bulb-like thickening of the hair peg (Fig 2C, ¢lled
arrow) and di¡erentiation of the bulbous peg cells into matrix
cells and progeny thereof, COX-2 expression became restricted
to basal ORS and sebaceous gland cells of growing hair follicles
(Fig 2D). Up to P12, i.e., over the period of ongoing hair follicle
morphogenesis and development of IFE toward the typical three-
layered adult phenotype, COX-2 was found in the ORS cells
of the distal but also of the proximal hair follicles as well as in
basal sebaceous gland cells and in the basal interfollicular
compartment. (Fig 2D,D inset,E). During the subsequent
synchronous phases of hair cycles, COX-2 expression declined
in catagen at P17 (Fig 2F) and was barely detectable in telogen
hair follicles at P21 (Fig 2G). COX-2 was reexpressed in ORS
cells of early anagen hair follicles at P25 (Fig 2H, inset) as well
as in ORS and basal sebaceous gland cells of late anagen hair
follicles at P28 (Fig 2H, I). COX-2 protein was barely detectable
in IFE and resting hair follicles of adults (P49; Mˇller-Decker
et al, 1998). ORS cells of anagen hair follicles induced by
depilation (12^18 d after depilation, data not shown) or
incisional wound healing in adult skin, however, were COX-2-
positive (Mˇller-Decker et al, 2002a).
Figure1. COX isozyme expression in embryonic and neonatal
mouse skin. (A) One microgram of total RNA isolated from embryos
13 and 15 d after gestation, from embryonic skin at day 18 after gestation
(E13^E18), or from postnatal dorsal skin at days 1 (P1) and 11 (P11) after
birth was reverse-transcribed and ampli¢ed with speci¢c primer sets for
COX-1 and COX-2, as described under Materials and Methods. b-Actin
was run as an internal control. Markers were MBI Fermentas M1,GeneRu-
ler 1-kb DNA ladder; and M2, pUC19 DNA/MspI; arrow, 500-bp fragment.
(B) Ten micrograms of total RNA isolated from dorsal skin with develop-
ing hair follicles at P12, with catagen hair follicles at P17, with telogen hair
follicles at P21, with hair follicles in ¢rst anagen cycle at P28, and from
adult dorsal skin at P49 with telogen hair follicles were subjected to north-
ern blot hybridization using COX isozyme-speci¢c cDNA probes. (Top)
Hybridization with COX-2 cDNA; (middle) hybridization with COX-1
cDNA; (bottom) RNA loading control showing ethidium-bromide-stained
18S rRNA signals. (C) Immunoblot analysis of COX isozyme expression
in skin of E17 embryos and in skin of P8, P20, and P49. Arrows on right,
COX-1-, COX-2-, b-actin-, and 18S rRNA-speci¢c signals.
CYCLOOXYGENASES AND HAIR FOLLICLES 663VOL. 121, NO. 4 OCTOBER 2003
COX-1 showed a di¡erent pattern of expression. Immuno-
signals were detected in spinous and granular keratinocytes
of the suprabasal compartment at E15^E18 but not in the
developing hair follicle (Fig 2J). Irrespective of hair follicle
cycling and epidermal thinning toward the adult phenotype,
this pattern of expression was detected in skin through day 28
after birth as well as in skin of 7-week-old mice (Fig 2K^O;
Mˇller-Decker et al, 1998). In addition, dendritic cells located
interfollicularly and in the distal portion of the hair follicle of
developing neonatal (P8^P28, Fig 2K,M^O) and adult skin
(data not shown) were COX-1-positive.
COX isozyme expression in embryonic skin (E18) correlated
with PGE2 and PGF2a levels of 26487535 and 11457243 pg/mg
protein7SD (n¼ 5), respectively. In skin of 7-week-old mice
the corresponding values were 6987361 and 6307386 pg/mg
protein7SD (n¼ 5).
PGE2 signals through EP receptors consisting of four subtypes,
EP1, EP2, EP3, and EP4. Using RT-PCR, mRNA of all
subtypes was detected from E13 to P11 (Fig 3A). According to
immunoblot analysis the four receptors showed a subtype-
dependent expression pattern in the course of hair follicle
morphogenesis and hair follicle cycling (Fig 3B). EP2 receptor
protein was identi¢ed in embryonic (E18), postnatal (P1 through
P20), and adult skin (P49). EP1 and EP4 immunosignals were
also found in all these samples with stronger signals in skin with
catagen (P17^P20) and telogen hair follicles (P49). The expression
of EP3 receptor protein was restricted to E18 and P1.
Precocious entry into the ¢rst hair follicle cycle and alopecia
in COX-2 transgenics To determine the e¡ects of COX-2
expression on pelage hair follicles in dorsal skin, transgenic mice
were generated expressing a COX-2 transgene under the control
of a K5 promoter in basal cells of the IFE and the pilosebaceous
appendage of skin (Neufang et al, 2001). Homozygous COX-2
overexpression in the skin as well as in the epidermis (Fig 4A)
occurred at the expected locations, i.e., in the basal cells of the
sebaceous gland and the ORS (Fig 4B) and the IFE (not
shown). COX-2 overexpression resulted in highly elevated PGE2
levels in the skin of adult mice (Fig 4C) and correlated with the
sparse hair coat (Fig 4E).
As documented by histological analysis, transgenic over-
expression of COX-2 did not alter early stages of postnatal hair
follicle morphogenesis as shown for P4 (Fig 5A,D). In
transgenic skin at P11, however, mainly catagen follicles were
observed, whereas in the skin of age-matched wild-type mice
growing hair follicles predominated. This indicates a precocious
entry into the catagen phase of the ¢rst hair growth cycle in
transgenics (Fig 5B,E). Thereafter, the regular hair follicle
Figure 2. COX isozyme expression during embryonic and neonatal development of mouse epidermis and the pilosebaceous unit as well as
during the ¢rst postnatal hair cycle. Cryosections of dorsal mouse skin were stained for the presence of COX isozymes by immunohistochemistry using
COX-isozyme-selective antibodies and diaminobenzidine as a substrate. (A^J) COX-2 stainings of skin from (A) E13, (B) E15, (C, including inset) E18 em-
bryos and (D) from 4-d-old, (D, inset) 8-d-old, and (E) 12-d-old neonatal mice with developing hair follicles; (F) of skin with catagen hair follicles from a
17-d-old neonatal mouse; (G) of skin with telogen hair follicles from a 21-d-old neonatal mouse; (H, inset) of a skin with early anagen at P25; and (H,I) late
anagen hair follicles from 28-d-old neonatal mice. COX-2 immunosignals were localized to the epithelial precursors of skin (A, arrow), to the basal (B,C,
arrow b), and peridermal (B, arrow p) layers of embryonic skin, to basal IFE (D, inset), to ORS cells of growing hair follicles (C,D,E,H,H inset, arrow ors), and to
basal cells of the sebaceous glands (D,I, arrow bsg). (J^O) COX-1 stainings of skin (J) from E18 embryo and (K,L) with developing hair follicles from an 8-d-
old neonatal, (M) with catagen hair follicles from a 17-d-old neonatal, (N) with telogen hair follicles from a 21-d-old neonatal, (O) with anagen hair
follicles from a 28-d-old neonatal mice. COX-1 immunosignals were localized to the suprabasal spinous and granular layers of epidermis (J,K, sb), as well
as to dendritic cells within IFE and the distal part of the hair follicles (K,M,N,O, arrow dc). Original magni¢cations: 100 (L), 160 (F,H,M,O),  200 (C
inset), 400 (C^E,G,J,N), 630 (A,B,D inset,H inset,I,K).
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staging in wild-type mice with prevailing catagen hair follicles
at P17 (Fig 5C), catagen and telogen follicles at P20 (Fig 5G),
predominantly anagen follicles at P29 (Fig 5H), and only
telogen follicles at P49 (Fig 5I) was strongly disturbed in COX-2
transgenic skin. The e¡ects of transgenic COX-2 culminated in a
strong predominance of catagen hair follicles instead of telogen
hair follicles at P49 (Fig 5F, J^L). The quantitative histo-
morphometric analysis revealed a percentage distribution of
catagen, telogen, and anagen hair follicles of 67% to 7% to 26%
in skin sections of transgenics compared with 14% to 0% to 86%
in wild-type skin at P11 (Fig 6A,B). In wild-type skin, however,
89% of hair follicles had entered the catagen phase not until P17,
whereas 41% catagen follicles were found in transgenic skin at
this time point. Signi¢cant di¡erences in hair follicle staging
were also found at P20, P29, and P49. At P49, the latest time
point of synchronized hair follicle cycling in wild-type mouse
skin, 85% of follicles were telogen and 15% were anagen,
whereas 94% of follicles were catagen and 6% anagen in COX-
2 transgenic skin (Fig 6A,B).
At the age of 3^10 mo mice had developed an alopecia that was
characterized on a histological level by a loss of hair follicles.
Only a few hair follicles £anked completely hairless areas of
transgenic skin compared to the skin of 10-mo-old wild-type
mice (Fig 5M^O). On the other hand, the sparse hair coat
visible early after birth is due to a reduced follicle density and
a delayed emergence of the hair shafts (Neufang et al, 2001).
In addition, substantial sebaceous gland hyperplasia became
apparent in transgenic skin around P29 (Fig 5H,K).
When transgenic mice were fed the COX-2-selective inhibitor
valdecoxib (Talley et al, 2000) for 3 mo postnatally, PGE2 levels in
dorsal skin were similar to those of wild-type skin, whereas
transgenic littermates fed with a drug-free control diet had
highly elevated PGE2 levels (Fig 4C). Moreover, the trans-
gene-characteristic impairment of the hair coat did not develop
under valdecoxib treatment, showing that valdecoxib-caused
suppression of COX-2 activity was responsible for this e¡ect
(Fig 4E,F).
DISCUSSION
As shown here, the spatiotemporal pattern of COX-1 expression
di¡ers from that of COX-2 during embryonic and early postnatal
Figure 3. EP receptor expression in embryonic
and neonatal mouse skin. (A) One microgram of
total RNA isolated from E13 and E15 embryos,
from embryonic skin at E18, and from postnatal
dorsal skin at P1 and P11 was reverse-transcribed
and ampli¢ed with speci¢c primer sets for EP1
EP4 receptors as described under Materials and
Methods. b-Actin was run as an internal control.
Arrows on right, EP receptor subtype-speci¢c ampli-
cons. Markers were MBI Fermentas M1 and M2; ar-
rows on left, 500-bp fragment. (B) Immunoblot
analysis of EP receptor isoforms EP1, EP2, EP3,
and EP4 in skin of E18 embryos and in skin of
P1, P11, P17, P20, and P49. Protein loading control
showing b-actin signals. Arrows, EP receptor sub-
type-speci¢c immunosignals. Note for EP-2 recep-
tor 45- and approximately 52-kDa signals which
are reported to represent partial and fully glycosy-
lated receptor proteins (Konger et al, 2002).
Figure 4. Suppression of the COX-2 transgene-induced PG levels in
dorsal mouse skin correlates with suppression of alopecia. (A) Ex-
pression levels of COX-2 protein in skin (S) and epidermis (E) of hetero-
zygous (þ /^) and homozygous (þ /þ ) transgenic mice compared to
age-matched wild-type mice (wt). PC, COX-2 positive control. (B) COX-2
staining of a catagen hair follicle from skin of a 6-mo-old K5 COX-2 trans-
genic mouse. Note COX-2 expression in basal cells of ORS and sebaceous
glands. Original magni¢cation:  630. (C) The levels (mean7SEM, n¼ 3)
of PGE2 were determined for the dorsal skin of wild-type NMRI (wt, n¼ 3),
K5 COX-2 transgenic mice fed with a control diet (tr, n¼ 3), and K5 COX-
2-transgenic mice receiving a valdecoxib-containing diet (tr/valdecoxib, n¼ 3).
The gross phenotypes are shown (D) for a wild-type, (E) for a K5 COX-2-
transgenic, and (F) for a valdecoxib-treated K5 COX-2-transgenic mouse.
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development of mouse epidermis and its pilosebaceous appen-
dage. Whereas keratinocytes of adult skin express COX-1, but
not COX-2 (Mˇller-Decker et al, 1998; Goldyne 2000), a strong
expression of both isoforms was found in embryonic epidermis.
COX-1 expression became detectable upon strati¢cation of the
epidermis in spinous and granular layers and persisted until P8^
P9, i.e., when IFE started thinning toward the adult phenotype.
Afterward throughout life, epidermal COX-1was restricted to a
few individual cells scattered throughout the IFE. Moreover, at
about P8, COX-1 protein was found in dendritic cells, which
were localized in the IFE and the distal part of the hair follicle.
Whether these COX-1-positive cells represent g/d-T cell-recep-
tor-positive lymphocytes, which are the predominant immuno-
cytes detectable in early postnatal epidermis, or other dendritic
cell types such as Langerhans cells (Paus et al, 1998), remains to
be clari¢ed. This expression in dendritic cells may indicate a
function of COX-1 in skin immune reactions (Uhrade et al,
1988) besides its role in normal tissue homeostasis (Tiano et al,
2002).
During embryonic development of the epidermis, the onset of
COX-2 expression preceded that of COX-1.This observation was
not unexpected, since various embryonic tissue types other than
skin have been described to express COX-2 (Komho¡ et al, 1997;
Maslinska et al, 1999; Kirschenbaum et al, 2000; Khan et al, 2001).
In skin, COX-2 expression appeared ¢rst in epithelial precursor
cells of the epidermis and continued during strati¢cation. COX-2
Figure 5. K5 promoter-driven COX-2 overexpression causes a pronounced hair phenotype in dorsal mouse skin. Representative pictures of
hematoxylin/eosin-stained longitudinal sections of dorsal skin from 4-d-old (A,D), 11-d-old (B,E), 17-d-old (C,F), 20-d-old (G,J), 29-d-old (H,K), 7-week-
old (I,L), 6-mo-old (N), and 10-mo-old (M,O) wild-type (A^C,G^I,M) and homozygous K5 COX-2 transgenic (D^F,J^L,N,O) mice. Note the precocious
entry of hair follicles into catagen stage at P11 (E) and subsequent asynchronous hair follicle cycling (F,J^L), hairless areas (N,O), and sebaceous gland
hyperplasia (K,L,N,O) in transgenic skin. Original magni¢cations:  100 (A^O).
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was mainly found in basal and peridermal layers. During hair fol-
licle morphogenesis, COX-2 appeared in all cells of elongated
hair germs and hair pegs of stages 2 and 3 (Paus et al, 1999),
whereas dermal papilla cells were negative. In the course of the
gradual transition of early-stage hair follicles into fully di¡eren-
tiated follicles after birth, COX-2 expression became restricted to
basal ORS and sebaceous gland cells. COX-2 expression de-
clined, when follicles entered catagen, and was barely detectable
in telogen follicles. COX-2 protein arose in basal ORS and se-
baceous gland cells, however, during the ¢rst and subsequent
anagen stages. COX-2 was not found in the dermal papilla of
adult anagen hair follicles, con¢rming a previous study (Torii
et al, 2002). Thus, COX-2 expression and activity were associated
with embryonic/postnatal development of IFE and hair follicles,
both processes characterized by expansive tissue growth.
This view is in line with the transient upregulation of COX-2
in the course of a regenerative epidermal hyperplasia (Scholz et al,
1995; Mˇller-Decker et al, 1998, 2002a). Moreover, constitutive
COX-2 overexpression in basal epidermal keratinocytes induced
an autopromoted phenotype in dorsal epidermis (Mˇller-Decker
et al, 2002b) and an epidermal hyperplasia and dysplasia in tail
skin the latter being due to a delay of terminal di¡erentiation
rather than to a stimulation of cell proliferation (Neufang et al,
2001). Accordingly, knocking-out COX-2 curtailed the 12-O-
tetradecanoylphorbol-13-acetate-induced hyperplasia that was
caused by an accelerated terminal di¡erentiation (Tiano et al,
2002). In contrast, the sebaceous gland hyperplasia in COX-2
transgenics was due to a hyperproliferation of basal cells, which
¢nally led to an increased sebum production (Neufang et al,
2001).
First evidence for a functional role of COX-2 in hair follicle
physiology come from our analysis of hair follicle morphogenesis
and cycling in homozygous transgenic mice with K5 promoter-
driven COX-2 expression.With respect to the hair follicle, K14,
i.e. the obligatory type I partner of K5, is known to be expressed
in basal cells of early embryonic epidermis. This basal expression
ceases regionally in keratinocytes of the hair placode and the sub-
sequent early hair follicles of stages 2^5. It is, however, speci¢-
cally restored in the ORS once the hair follicle has reached an
almost complete tissue architecture toward the very late stage of
gestation and shortly after birth. K5 expression is maintained in
ORS during the entire follicle morphogenesis and all stages of
the subsequent hair cycles (Kopan and Fuchs, 1989; Winter et al,
1998; Pena et al, 1999). According to this K5 expression pattern,
transgenic COX-2 expression in the ORS is expected to initiate
only around birth and to continue throughout life irrespective of
follicular cycling. This pattern of transgenic COX-2 expression is
unscheduled compared with the expression of endogenous COX-
2 and correlated with a precocious entry of growing hair follicles
into the ¢rst catagen stage after birth. This suggests that aberrant
COX-2 expression and activity impair proper hair follicle mor-
phogenesis. A premature entry into the ¢rst catagen phase has
also been observed in mice with K14-driven neurotrophin-3 or
plakoglobin overexpression (Botchkarev et al, 1998; Charpentier
et al, 2000). This early change that is also observed in the skin
of COX-2 transgenics appears to be responsible for the sub-
sequent irregular hair follicle phasing. In addition, a premature
onset of catagen has been associated with certain hair growth
disorders including distinct forms of alopecia (Paus and
Cotsarelis, 1999). This may hold true for alopecia development in
COX-2 transgenic mice. This assumption is supported by the fact
that inhibition of COX-2-dependent PGE2 synthesis prevented
the development of alopecia. At the age of 6 mo, the COX-2-
induced alopecia seemed to be of a permanent type characteri-
zed by a loss of hair follicles. We did not, however, observe
scarring or signs of in£ammation or ¢brosis being reportedly
associated with the development of this type of alopecia (Paus
and Cotsarelis, 1999).
It has been shown that PGE2 acts locally in both an autocrine
and a paracrine manner via the speci¢c G-protein-coupled recep-
tors EP1 to EP4 (Narumiya et al, 1999). In this study we show a
di¡erential expression of PGE2 receptor proteins. EP1 and EP2
were present in embryonic and postnatal skin. EP3 protein ex-
pression was restricted to embryonic skin and P1, whereas EP4
protein increased around P20. According to preliminary results,
EP1 to EP3 receptors were similarly expressed in the skin of adult
(P49) COX-2 transgenic mice, whereas the EP4 receptor was
found to be downregulated. The role of EP4 receptor function
for the premature onset of catagen remains to be elucidated.
Although the localization of the EP receptor proteins is at present
unknown, there is evidence that keratinocytes are able to express
all subtypes (Konger et al, 1998, 2002; Thompson et al, 2001). Re-
cently, EP3 and EP4 transcripts could be located to distinct com-
partments of anagen hair follicles in depilated adult mouse skin.
EP4 mRNA occurred in ORS cells of the hair bulb, whereas
EP3 mRNA expression seemed to be restricted to dermal papilla
cells (Torii et al, 2002). These data suggest that cells of the lower
ORS are able to produce and to respond to PGE2. In addition,
COX-2-derived PGE2 in the ORS may act in a paracrine manner
on EP3-containing dermal papilla cells. In this context, it re-
mains to be clari¢ed whether COX-2-derived PGs are compo-
nents of signaling pathways such as neurotrophin-3 or
plakoglobin known to induce precocious catagen entry in trans-
genic mice (Botchkarev et al, 1998; Charpentier et al, 2000).
Although our data provide evidence for a role of COX-2 expres-
sion and activity in hair follicle biology, further studies need to
address the molecular mechanism of PG action in various cell
types involved in the regulation of hair follicles morphogenesis
and cycling, in particular the transition from the anagen to the
catagen stage.
Figure 6. Precocious entry into catagen stage in the skin of homo-
zygous K5 COX-2-transgenic mice.The percentage of hair follicles in
catagen (black bars), telogen (white bars), and anagen (red bars) stages were
evaluated by quantitative histomorphometry according to published criter-
ia (Mˇller-R˛ver et al, 2001) in skin sections of wild-type (A) and K5
COX-2 transgenic (B) mice on P11, P17, P20, P29, and P49. Signi¢cant dif-
ferences (po0.05^0.0005) were found between individual stages of follicles
in skin of K5 COX-2 transgenic versus wild-type mice, except for telogen
and anagen follicles at P11 and P49, respectively (indicated by a minus).
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